Andrea Maier and NAD Metabolism
A trial excerpt supports linking Andrea Maier's profile to NAD metabolism through blood measurements before and after NMN supplementation, but provides neither results nor her role in the trial.
Andrea Maier and NAD Metabolism
Materials on Andrea Maier, Professor of Medicine at the National University of Singapore, mention a trial that measured blood nicotinamide adenine dinucleotide (NAD) levels before and after supplementation with nicotinamide mononucleotide (NMN).
NAD metabolism includes its synthesis, availability, balance between oxidized and reduced forms, and roles in cellular signaling. NMN also appears as a separate topic linked to Maier in her profile.
The measurements before and after NMN supplementation provide a basis for this topic link. However, the available excerpt gives no trial name, design, participant details, dose, or supplementation duration. The results and Maier's role are also unknown. These data therefore cannot tell us whether blood NAD levels changed or whether any changes were associated with health benefits.
Explore the basis for the link and the NMN connection: Andrea Maier's profile
The edge rests on a specific measurement in a trial and makes its evidentiary limits clear.